Table of Contents Author Guidelines Submit a Manuscript
Anemia
Volume 2012, Article ID 603253, 13 pages
http://dx.doi.org/10.1155/2012/603253
Research Article

Diagnosis of Fanconi Anemia: Mutation Analysis by Multiplex Ligation-Dependent Probe Amplification and PCR-Based Sanger Sequencing

Department of Clinical Genetics, VU University Medical Center, Van der Boechorsttraat 7, 1081 BT Amsterdam, The Netherlands

Received 22 December 2011; Accepted 21 March 2012

Academic Editor: Stefan Meyer

Copyright © 2012 Johan J. P. Gille et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. P. de Winter and H. Joenje, “The genetic and molecular basis of Fanconi anemia,” Mutation Research, vol. 668, no. 1-2, pp. 11–19, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Vaz, H. Hanenberg, B. Schuster et al., “Mutation of the RAD51C gene in a Fanconi anemia-like disorder,” Nature Genetics, vol. 42, no. 5, pp. 406–409, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Stoepker, K. Hain, B. Schuster et al., “SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype,” Nature Genetics, vol. 43, no. 2, pp. 138–141, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Kim, F. P. Lach, R. Desetty, H. Hanenberg, A. D. Auerbach, and A. Smogorzewska, “Mutations of the SLX4 gene in Fanconi anemia,” Nature Genetics, vol. 43, no. 2, pp. 142–146, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Levitus, H. Joenje, and J. P. de Winter, “The Fanconi anemia pathway of genomic maintenance,” Cellular Oncology, vol. 28, no. 1-2, pp. 3–29, 2006. View at Google Scholar · View at Scopus
  6. A. J. Deans and S. C. West, “DNA interstrand crosslink repair and cancer,” Nature Reviews Cancer, vol. 11, no. 7, pp. 467–480, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. A. R. Meetei, J. P. de Winter, A. L. Medhurst et al., “A novel ubiquitin ligase is deficient in Fanconi anemia,” Nature Genetics, vol. 35, no. 2, pp. 165–170, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Blom, “Evolutionary clues to the molecular function of Fanconi anemia genes,” in Thesis, VU University Medical Center, Amsterdam, The Netherlands, 2006. View at Google Scholar
  9. S. C. West, “Molecular views of recombination proteins and their control,” Nature Reviews Molecular Cell Biology, vol. 4, no. 6, pp. 435–445, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Blom, H. J. van de Vrugt, Y. de Vries, J. P. de Winter, F. Arwert, and H. Joenje, “Multiple TPR motifs characterize the Fanconi anemia FANCG protein,” DNA Repair, vol. 3, no. 1, pp. 77–84, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Levitus, Q. Waisfisz, B. C. Godthelp et al., “The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J,” Nature Genetics, vol. 37, no. 9, pp. 934–935, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. O. Levran, C. Attwooll, R. T. Henry et al., “The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia,” Nature Genetics, vol. 37, no. 9, pp. 931–933, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. A. R. Meetei, A. L. Medhurst, C. Ling et al., “A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M,” Nature Genetics, vol. 37, no. 9, pp. 958–963, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. O. Levran, T. Erlich, N. Magdalena et al., “Sequence variation in the Fanconi anemia gene FAA,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 24, pp. 13051–13056, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Magdalena, D. V. Pilonetto, M. A. Bitencourt et al., “Frequency of Fanconi anemia in Brazil and efficacy of screening for the FANCA 3788-3790del mutation,” Brazilian Journal of Medical and Biological Research, vol. 38, no. 5, pp. 669–673, 2005. View at Google Scholar · View at Scopus
  16. O. Levran, R. Diotti, K. Pujara, S. D. Batish, H. Hanenberg, and A. D. Auerbach, “Spectrum of sequence variations in the FANCA gene: an International Fanconi Anemia Registry (IFAR) study,” Human Mutation, vol. 25, no. 2, pp. 142–149, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. A. J. Tipping, T. Pearson, N. V. Morgan et al., “Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 10, pp. 5734–5739, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Callen, J. A. Casado, M. D. Tischkowitz et al., “A common founder mutation in FANCA underlies the world's highest prevalence of Fanconi anemia in Gypsy families from Spain,” Blood, vol. 105, no. 5, pp. 1946–1949, 2005. View at Google Scholar
  19. A. P. Gillio, P. C. Verlander, S. D. Batish, P. F. Giampietro, and A. D. Auerbach, “Phenotypic consequences of mutations in the Fanconi anemia FAC gene: an international Fanconi anemia registry study,” Blood, vol. 90, no. 1, pp. 105–110, 1997. View at Google Scholar · View at Scopus
  20. M. Futaki, T. Yamashita, H. Yagasaki et al., “The IVS4 + 4A to T mutation of the Fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients,” Blood, vol. 95, no. 4, pp. 1493–1498, 2000. View at Google Scholar · View at Scopus
  21. M. A. Whitney, H. Saito, P. M. Jakobs, R. A. Gibson, R. E. Moses, and M. Grompe, “A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews,” Nature Genetics, vol. 4, no. 2, pp. 202–205, 1993. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Kutler and A. Auerbach, “Fanconi anemia in Ashkenazi Jews,” Familial Cancer, vol. 3, no. 3-4, pp. 241–248, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Faivre, P. Guardiola, C. Lewis et al., “Association of complementation group and mutation type with clinical outcome in Fanconi anemia,” Blood, vol. 96, no. 13, pp. 4064–4070, 2000. View at Google Scholar · View at Scopus
  24. T. Yamashita, N. Wu, G. Kupfer et al., “Clinical variability of Fanconi anemia (type C) results from expression of an amino terminal truncated Fanconi anemia complementation group C polypeptide with partial activity,” Blood, vol. 87, no. 10, pp. 4424–4432, 1996. View at Google Scholar · View at Scopus
  25. H. Joenje, “Fanconi anaemia complementation groups in Germany and the Netherlands,” Human Genetics, vol. 97, no. 3, pp. 280–282, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Kalb, K. Neveling, H. Hoehn et al., “Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype,” American Journal of Human Genetics, vol. 80, no. 5, pp. 895–910, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Demuth, M. Wlodarski, A. J. Tipping et al., “Spectrum of mutations in the Fanconi anaemia group G gene, FANCG/XRCC9,” European Journal of Human Genetics, vol. 8, no. 11, pp. 861–868, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. A. D. Auerbach, J. Greenbaum, K. Pujara et al., “Spectrum of sequence variation in the FANCG gene: an International Fanconi Anemia Registry (IFAR) study,” Human Mutation, vol. 21, no. 2, pp. 158–168, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Yagasaki, T. Oda, D. Adachi et al., “Two common founder mutations of the fanconi anemia group G gene FANCG/XRCC9 in the Japanese population,” Human mutation, vol. 21, no. 5, p. 555, 2003. View at Google Scholar · View at Scopus
  30. N. V. Morgan, F. Essop, I. Demuth et al., “A common Fanconi anemia mutation in black populations of sub-Saharan Africa,” Blood, vol. 105, no. 9, pp. 3542–3544, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Rosendorff and R. Bernstein, “Fanconi's anemia—chromosome breakage studies in homozygotes and heterozygotes,” Cancer Genetics and Cytogenetics, vol. 33, no. 2, pp. 175–183, 1988. View at Google Scholar · View at Scopus
  32. B. P. Alter, “Diagnostic evaluation of FA,” in Fanconi Anemia: Guidelines for Diagnosis and Management, M. E. Eiler et al., Ed., pp. 33–48, Fanconi Anemia Research Fund, Eugene, Ore, USA, 2008. View at Google Scholar
  33. M. Castella, R. Pujol, E. Callen et al., “Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations,” Blood, vol. 117, no. 14, pp. 3759–3769, 2011. View at Google Scholar
  34. N. Ameziane, A. Errami, F. Léveillé et al., “Genetic subtyping of Fanconi anemia by comprehensive mutation screening,” Human Mutation, vol. 29, no. 1, pp. 159–166, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. J. R. Lo Ten Foe, M. T. Barel, P. Thuß, M. Digweed, F. Arwert, and H. Joenje, “Sequence variations in the Fanconi anaemia gene, FAC: pathogenicity of 1806insA and R548X and recognition of D195V as a polymorphic variant,” Human Genetics, vol. 98, no. 5, pp. 522–523, 1996. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Hanenberg, S. D. Batish, K. E. Pollok et al., “Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool,” Experimental Hematology, vol. 30, no. 5, pp. 410–420, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Chandra, O. Levran, I. Jurickova et al., “A rapid method for retrovirus-mediated identification of complementation groups in Fanconi anemia patients,” Molecular Therapy, vol. 12, no. 5, pp. 976–984, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. T. N. Kaiser, A. Lojewski, C. Dougherty, L. Juergens, E. Sahar, and S. A. Latt, “Flow cytometric characterization of the response of Fanconi's anemia cells to mitomycin C treatment,” Cytometry, vol. 2, no. 5, pp. 291–297, 1982. View at Google Scholar · View at Scopus
  39. F. O. Pinto, T. Leblanc, D. Chamousset et al., “Diagnosis of Fanconi anemia in patients with bone marrow failure,” Haematologica, vol. 94, no. 4, pp. 487–495, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Hirsch, A. Shimamura, L. Moreau et al., “Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood,” Blood, vol. 103, no. 7, pp. 2554–2559, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. J. E. Wagner, J. Tolar, O. Levran et al., “Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia,” Blood, vol. 103, no. 8, pp. 3226–3229, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Offit, O. Levran, B. Mullaney et al., “Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia,” Journal of the National Cancer Institute, vol. 95, no. 20, pp. 1548–1551, 2003. View at Google Scholar · View at Scopus
  43. S. Reid, D. Schindler, H. Hanenberg et al., “Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer,” Nature Genetics, vol. 39, no. 2, pp. 162–164, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. B. Xia, J. C. Dorsman, N. Ameziane et al., “Fanconi anemia is associated with a defect in the BRCA2 partner PALB2,” Nature Genetics, vol. 39, no. 2, pp. 159–161, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Somyajit, S. Subramanya, and G. Nagaraju, “RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer,” Carcinogenesis, vol. 31, no. 12, pp. 2031–2038, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. J. P. Schouten, C. J. McElgunn, R. Waaijer, D. Zwijnenburg, F. Diepvens, and G. Pals, “Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification,” Nucleic acids research, vol. 30, no. 12, p. e57, 2002. View at Google Scholar · View at Scopus
  47. A. R. Gennery, M. A. Slatter, A. Bhattacharya et al., “The clinical and biological overlap between Nijmegen Breakage syndrome and Fanconi anemia,” Clinical Immunology, vol. 113, no. 2, pp. 214–219, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. P. van der Lelij, A. B. Oostra, M. A. Rooimans, H. Joenje, and J. P. de Winter, “Diagnostic overlap between Fanconi anemia and the cohesinopathies: roberts syndrome and Warsaw Breakage syndrome,” Anemia, vol. 2010, Article ID 565268, 7 pages, 2010. View at Publisher · View at Google Scholar
  49. J. R. Lo Ten Foe, M. L. Kwee, M. A. Rooimans et al., “Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance,” European Journal of Human Genetics, vol. 5, no. 3, pp. 137–148, 1997. View at Google Scholar · View at Scopus
  50. Q. Waisfisz, N. V. Morgan, M. Savino et al., “Spontaneous functional correction of homozygous Fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism,” Nature Genetics, vol. 22, no. 4, pp. 379–383, 1999. View at Publisher · View at Google Scholar · View at Scopus
  51. B. P. Alter, H. Joenje, A. B. Oostra, and G. Pals, “Fanconi anemia: adult head and neck cancer and hematopoietic mosaicism,” Archives of Otolaryngology, vol. 131, no. 7, pp. 635–639, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. A. L. Medhurst, E. H. Laghmani, J. Steltenpool et al., “Evidence for subcomplexes in the Fanconi anemia pathway,” Blood, vol. 108, no. 6, pp. 2072–2080, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. B. P. Alter, C. L. Frissora, D. S. Halperin et al., “Fanconi's anaemia and pregnancy,” British Journal of Haematology, vol. 77, no. 3, pp. 410–418, 1991. View at Google Scholar · View at Scopus
  54. P. S. Rosenberg, H. Tamary, and B. P. Alter, “How high are carrier frequencies of rare recessive syndromes? Contemporary estimates for Fanconi anemia in the United States and Israel,” American Journal of Medical Genetics A, vol. 155, no. 8, pp. 1877–1883, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. A. D. Auerbach, “Fanconi anemia,” in Diagnosis and Treatment of the Unborn Child, M. I. New, Ed., pp. 27–35, Idelson-Gnocchi, Naples, Italy, 1999. View at Google Scholar
  56. A. Bechtold, R. Kalb, K. Neveling et al., “Prenatal diagnosis of Fanconi anemia: functional and molecular testing,” in Fanconi Anemia. A Paradigmatic Disease for the Understanding of Cancer and Aging, D. Schindler and H. Hoehn, Eds., Monographs in Human Genetics, pp. 131–148, Karger, Basel, Switzerland, 2007. View at Google Scholar
  57. A. Merrill, L. Rosenblum-Vos, D. A. Driscoll, K. Daley, and K. Treat, “Prenatal diagnosis of Fanconi anemia (Group C) subsequent to abnormal sonographic findings,” Prenatal Diagnosis, vol. 25, no. 1, pp. 20–22, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. D. I. Kutler, B. Singh, J. Satagopan et al., “A 20-year perspective on the International Fanconi Anemia Registry (IFAR),” Blood, vol. 101, no. 4, pp. 1249–1256, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. P. C. Verlander, A. Kaporis, Q. Liu, Q. Zhang, U. Seligsohn, and A. D. Auerbach, “Carrier frequency of the IVS4 + 4 A—> T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population,” Blood, vol. 86, no. 11, pp. 4034–4038, 1995. View at Google Scholar · View at Scopus
  60. M. Berwick, J. M. Satagopan, L. Ben-Porat et al., “Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer,” Cancer Research, vol. 67, no. 19, pp. 9591–9596, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Tischkowitz, D. F. Easton, J. Ball, S. V. Hodgson, and C. G. Mathew, “Cancer incidence in relatives of British Fanconi anaemia patients,” BMC Cancer, vol. 8, article 257, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. N. G. Howlett, T. Taniguchi, S. Olson et al., “Biallelic inactivation of BRCA2 in Fanconi anemia,” Science, vol. 297, no. 5581, pp. 606–609, 2002. View at Publisher · View at Google Scholar · View at Scopus
  63. E. Levy-Lahad and E. Friedman, “Cancer risks among BRCA1 and BRCA2 mutation carriers,” British Journal of Cancer, vol. 96, no. 1, pp. 11–15, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. N. Rahman, S. Seal, D. Thompson et al., “PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene,” Nature Genetics, vol. 39, no. 2, pp. 165–167, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. M. J. Garcia, V. Fernandez, A. Osorio et al., “Analysis of FANCB and FANCN/PALB2 Fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families,” Breast Cancer Research and Treatment, vol. 113, no. 3, pp. 545–551, 2009. View at Google Scholar
  66. A. Meindl, H. Hellebrand, C. Wiek et al., “Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene,” Nature Genetics, vol. 42, no. 5, pp. 410–414, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. A. R. Meetei, M. Levitus, Y. Xue et al., “X-linked inheritance of Fanconi anemia complementation group B,” Nature Genetics, vol. 36, no. 11, pp. 1219–1224, 2004. View at Publisher · View at Google Scholar · View at Scopus